newsfilter
← Latest News
Business Wire·

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division ((Bruker Corporation, NASDAQ:BRKR) announces the European launch of MyGenius PRO®, a fully automated, sample-to-answer (S2A)